148 related articles for article (PubMed ID: 36674469)
1. Synthesis and Antibacterial Evaluation of Ciprofloxacin Congeners with Spirocyclic Amine Periphery.
Lukin A; Komarova K; Vinogradova L; Rogacheva E; Kraeva L; Krasavin M
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674469
[TBL] [Abstract][Full Text] [Related]
2. Exploration of Spirocyclic Derivatives of Ciprofloxacin as Antibacterial Agents.
Lukin A; Chudinov M; Vedekhina T; Rogacheva E; Kraeva L; Bakulina O; Krasavin M
Molecules; 2022 Jul; 27(15):. PubMed ID: 35956812
[TBL] [Abstract][Full Text] [Related]
3. Design, Synthesis and Molecular Docking of 1-Cyclopropyl-6- Fluoro-4-Oxo-7-{4-[2-(4-Substituted-Phenyl)-2-(Substituted)-Ethyl] -1-Piperazinyl}-1,4-Dihydroquinoline-3-Carboxylic Acid as an Antimicrobial Agents.
Patel MM; Patel LJ
Curr Drug Discov Technol; 2017; 14(4):255-269. PubMed ID: 28240185
[TBL] [Abstract][Full Text] [Related]
4. 4-Substituted 4-(1H-1,2,3-triazol-1-yl)piperidine: novel C7 moieties of fluoroquinolones as antibacterial agents.
Huang X; Zhang A; Chen D; Jia Z; Li X
Bioorg Med Chem Lett; 2010 May; 20(9):2859-63. PubMed ID: 20347299
[TBL] [Abstract][Full Text] [Related]
5. Antibacterial and antibiofilm activity of permanently ionized quaternary ammonium fluoroquinolones.
Fedorowicz J; Cruz CD; Morawska M; Ciura K; Gilbert-Girard S; Mazur L; Mäkkylä H; Ilina P; Savijoki K; Fallarero A; Tammela P; Sączewski J
Eur J Med Chem; 2023 Jun; 254():115373. PubMed ID: 37084595
[TBL] [Abstract][Full Text] [Related]
6. The synthesis and biological evaluation of a novel series of C7 non-basic substituted fluoroquinolones as antibacterial agents.
Huang X; Chen D; Wu N; Zhang A; Jia Z; Li X
Bioorg Med Chem Lett; 2009 Aug; 19(15):4130-3. PubMed ID: 19539467
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo antibacterial activities of E-4497, a new 3-amine-3-methyl-azetidinyl tricyclic fluoroquinolone.
Gargallo-Viola D; Esteve M; Llovera S; Roca X; Guinea J
Antimicrob Agents Chemother; 1991 Mar; 35(3):442-7. PubMed ID: 2039195
[TBL] [Abstract][Full Text] [Related]
8. New 7-[4-(4-(un)substituted)piperazine-1-carbonyl]- piperazin-1-yl] derivatives of fluoroquinolone: synthesis and antimicrobial evaluation.
Chen PT; Lin WP; Lee AR; Hu MK
Molecules; 2013 Jun; 18(7):7557-69. PubMed ID: 23807580
[TBL] [Abstract][Full Text] [Related]
9. 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1H-pyrrol-1-yl)-quinoline-3-carb oxylic acid, a new fluorinated compounds of oxacin family with high broad-spectrum antibacterial activities.
Stefancich G; Artico M; Corelli F; Massa S; Panico S; Simonetti N
Farmaco Sci; 1985 Apr; 40(4):237-48. PubMed ID: 3926533
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and in vitro antibacterial activity of 7-(3-alkoxyimino-4-methyl-4-methylaminopiperidin-1-yl)-fluoroquinolone derivatives.
Zhang YB; Feng LS; You XF; Guo Q; Guo HY; Liu ML
Arch Pharm (Weinheim); 2010 Mar; 343(3):143-51. PubMed ID: 20186866
[TBL] [Abstract][Full Text] [Related]
11. Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity.
Kassab AE; Gedawy EM
Eur J Med Chem; 2018 Apr; 150():403-418. PubMed ID: 29547830
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, molecular docking study, and antibacterial evaluation of some new fluoroquinolone analogues bearing a quinazolinone moiety.
Norouzbahari M; Salarinejad S; Güran M; Şanlıtürk G; Emamgholipour Z; Bijanzadeh HR; Toolabi M; Foroumadi A
Daru; 2020 Dec; 28(2):661-672. PubMed ID: 33030668
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and in vitro antibacterial activity of 7-(4-alkoxyimino-3-aminomethylpiperidin-1-yl)fluoroquinolone derivatives.
Chai Y; Wang J; Liu M; Yi H; Sun L; You X; Guo H
Bioorg Med Chem Lett; 2011 Jun; 21(11):3377-80. PubMed ID: 21515052
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and in-vitro antibacterial activity of 7-(3-aminopyrrolo[3,4-c]pyrazol-5(2H,4H,6H)-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid derivatives.
Guo X; Bai XG; Li YL; An ZJ; Xu LX; Han LY; Liu ML; Guo HY; Wang YC
Arch Pharm (Weinheim); 2011 Aug; 344(8):523-9. PubMed ID: 21656543
[TBL] [Abstract][Full Text] [Related]
15. Delafloxacin--A novel fluoroquinolone for the treatment of ciprofloxacin-resistant Pseudomonas aeruginosa in patients with cystic fibrosis.
Millar BC; McCaughan J; Rendall JC; Moore JE
Clin Respir J; 2021 Jan; 15(1):116-120. PubMed ID: 32790958
[TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis and Antibacterial Evaluation of 1-[(1R,2S)-2-Fluorocyclopropyl]ciprofloxacin-1,2,4-triazole-5(4H)-thione Hybrids.
Gao Y; Na LX; Xu Z; Zhang S; Wang AP; Lü K; Guo HY; Liu ML
Chem Biodivers; 2018 Oct; 15(10):e1800261. PubMed ID: 29987907
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of novel ciprofloxacin analogues and evaluation of their anti-proliferative effect on human cancer cell lines.
Suresh N; Nagesh HN; Sekhar KV; Kumar A; Shirazi AN; Parang K
Bioorg Med Chem Lett; 2013 Dec; 23(23):6292-5. PubMed ID: 24138941
[TBL] [Abstract][Full Text] [Related]
18. [Synthesis and antibacterial activity of 7-(7-aminomethyl-5-azaspiro [2,4] hept-5-yl)-1-cyclopropyl-6-fluoro-8-methoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid and its analogues].
Qi JJ; Guo HY; Liu ML; Sun LY
Yao Xue Xue Bao; 2004 Mar; 39(3):184-9. PubMed ID: 15171652
[TBL] [Abstract][Full Text] [Related]
19. Development of in vitro resistance to fluoroquinolones in Pseudomonas aeruginosa.
Zhao L; Wang S; Li X; He X; Jian L
Antimicrob Resist Infect Control; 2020 Aug; 9(1):124. PubMed ID: 32758289
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and in vitro antimicrobial study of Schiff base and thiazolidinone of 1-cyclopropyl-6-fluoro-7-[4-(2,3-dichlorophenyl)piperazin-1-yl]-4-quinolone.
Patel NB; Patel SD
Acta Pol Pharm; 2010; 67(1):45-53. PubMed ID: 20210078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
